SCHEMBL30935679

SCHEMBL30935679

Cc1ccc(-c2ncon2)cc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
TDP1 Q9NUW8 3/20 0.39
CASP1 P29466 1/20 0.39
MAPT P10636 2/20 0.38
KMO O15229 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
CYP3A4 P08684 2/20 0.37
TSHR P16473 3/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.36
S1PR1 P21453 2/20 0.36
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529766 0.84 TDP1 (0.48) ALDH1A1KDM4ESMN1; SMN2TDP1MAPT
SCHEMBL310646 0.79 NISCH (0.41) MAPTKMOCYP3A4BACE1
SCHEMBL15331513 0.77 KMO (0.36) RAB9ANPC1MAPTKMOPKM
SCHEMBL14951064 0.76 AURKA (0.39) KMOCYP3A4NTRK1BACE1LRRK2
SCHEMBL9299621 0.76 S1PR1 (0.47) ALDH1A1RAB9ANPC1TDP1MAPT
SCHEMBL23166186 0.76 BACE1 (0.40) ALDH1A1TDP1MAPTKMOLMNA
SCHEMBL1027167 0.74 RAB9A (0.53) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL70247 0.74 RAB9A (0.48) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL6854121 0.74 NPC1 (0.43) ALDH1A1SMN1; SMN2RAB9ANPC1TDP1
SCHEMBL31261544 0.73 MAPT (0.51) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630424-A1 COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS Third Harmonic Bio, Inc. (US) 2025-10-15 EP disclosed
US-20240254119-A1 COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS Calixis Inc. 2024-08-01 US disclosed
WO-2024124002-A1 COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS THIRD HARMONIC BIO, INC. (US) 2024-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254119-A1 COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS KIT, AURKC, PRKCE ALDH1A1 2871/4885KDM4E 719/4885SMN1; SMN2 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.